ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 88 filers reported holding ONCOCYTE CORP in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $352,000 | -82.1% | 162,300 | -70.7% | 0.00% | -75.0% |
| Q3 2021 | $1,970,000 | -36.1% | 553,324 | +3.0% | 0.00% | -42.9% |
| Q2 2021 | $3,083,000 | +40.9% | 537,121 | +27.4% | 0.01% | +16.7% |
| Q1 2021 | $2,188,000 | +504.4% | 421,542 | +122.3% | 0.01% | +200.0% |
| Q2 2020 | $362,000 | +1031.2% | 189,649 | +1358.8% | 0.00% | – |
| Q1 2020 | $32,000 | -27.3% | 13,000 | -37.8% | 0.00% | – |
| Q3 2019 | $44,000 | – | 20,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 14,716,204 | $20,456,000 | 1.61% |
| PURA VIDA INVESTMENTS, LLC | 6,022,534 | $8,371,000 | 0.43% |
| P.A.W. CAPITAL CORP | 199,700 | $278,000 | 0.30% |
| Penbrook Management LLC | 229,425 | $319,000 | 0.28% |
| PERKINS CAPITAL MANAGEMENT INC | 39,725 | $55,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 201,047 | $279,000 | 0.05% |
| Private Wealth Partners, LLC | 150,000 | $209,000 | 0.02% |
| Phoenix Holdings Ltd. | 317,138 | $426,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 255,300 | $355,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 157,933 | $226,000 | 0.01% |